Cuba-Algeria Join Forces on Hepatitis B Vaccine

HAVANA TIMES, Feb. 3 – Cuban and Algerian companies agreed to jointly produce hepatitis B vaccines to meet a demand estimated at five million doses a year in that North African country. The agreement signed by Algeria’s Saidal pharmaceutical group and Cuba’s Heber Bistec firm includes the construction of a factory and technological transfer to the Algerian Pasteur Institute, reported IPS.